The measurement of injection pressure during the performance of peripheral nerve blocks can be pivotal to detect intraneural placement of the needle tip and thus avoid intrafascicular injection. However, injection pressure can only be measured along the injection line (tubing), which is influenced by several factors. The primary aim of this feasibility study was to describe and validate the principle of a novel nerve-block needle conceived for real-time continuous monitoring of injection pressures at the needle tip. Our secondary aim was to provide measurements and compare injection pressure values at the needle tip and in the injection line. Four porcine lower limb anatomic models were prepared and extraneural injections were performed with fractioned boluses of 2 ml saline at a controlled infusion rate of 10 ml.min À1 (0.16 ml.s À1 ). Injection pressure at the needle tip was monitored and compared with the pressure in the injection line. The system proved to be reliable. Thirty injections were successfully performed without technical failures. The mean (95%CI) difference between pressures at the needle tip and the injection line varied substantially from 14.33 (12.58-16.08) kPa at 0.5 ml injected volume to 41.56 (39.66-43.45) kPa at the end of the injection. This study demonstrates that the described system allows for real-time continuous monitoring of injection pressure at the needle tip. Moreover, this study shows that injection pressure values measured in the injection line cannot be assumed to be a reliable indicator of the injection pressure at the needle tip.
Introduction
The addition of ultrasound guidance for peripheral nerve block contributes to improvement in needle-tip location accuracy. However, this does not eliminate the risk of intraneural injection [1] [2] [3] . To prevent intraneural injection, the relative position of both the needle tip and the nerve should be continuously monitored. Although the recent tendency in clinical practice is to reduce this distance ever further, current limits in image definition of modern ultrasound machines in image definition impede the detailed viewing of millimetric anatomical structures. Moreover, minimal unintentional millimetric needle-tip displacement during local anaesthetic injection can occur. Failure to accurately define the anatomical boundaries of nerves may contribute to unintentional intraneural injections, even under real-time ultrasound guidance with inplane needle visualisation [1] [2] [3] [4] .
Permanent nerve damage after intraneural injection represents one of the most feared complications of peripheral nerve block. Irreversible neuropathy can lead to a devastating impact on a patient's quality of life, leading to loss of function and chronic pain [5] . Moreover, minor nerve lesions associated with temporary side-effects are one of the leading causes of medicolegal concerns. Intraneural needle placement can cause a neuropathy by two primary mechanisms: direct needle-tip trauma to nerve fibres [6] ; and increasing intraneural pressure following injection of a volume of liquid into a low-compliance structure [1, [6] [7] [8] [9] .
Feedback on the pressure generated during injection might contribute to the detection of intraneural needle-tip positioning because subepineurial, interfascicular or even intrafascicular injection generates high pressures. However, the subjective sensation of high injection pressures has been shown to be inaccurate in detecting an intraneural injection [10] .
The primary aim of this study was to describe and validate the principle of a novel system for real-time continuous injection pressure monitoring at the needle tip. The secondary aim was to provide measurements and compare injection pressure values at the needle tip and in the injection line.
Methods
A novel nerve block system with a sensing needle was tested. This sensing needle is a disposable device that consists of an optical fibre sensor embedded within the shaft of standard nerve block needle, which continuously measures injection pressure at the needle tip (Fig. 1 ). This prototype used a Stimuplex Ultra 22G 0.70 9 80 mm needle (B.Braun Melsungen AG, Melsungen, Germany). The flexible optical fibre connects directly to a control unit and software allows real-time visualisation and recording of injection profiles. The future commercial product will contain the optical fibre pressure sensor embedded within a range of disposable needle dimensions. The sensor consists of a Fabry-P erot optical cavity bonded to the tip of an optical fibre. The length of the cavity varies with pressure flexing the distal membrane. Pressure is thus measured by detecting the length of the cavity using a white-light interferometer, where light is sent from the control unit to the end of the fibre and the reflected light is detected and analysed. These optical sensors, that are already approved for use in several medical devices, are immune to electrical interference and are therefore compatible with electrostimulation.
Injection pressure at the needle tip (tip pressure) was continuously monitored with the sensing needle. To compare tip pressure to the pressure in the injection line (line pressure), a second and identical optical fibre pressure sensor was placed intraluminally at the connection between the syringe and the injection line (Fig. 2) , using a Tuohy Borst Adapter, Swivel Male Figure 1 The sensing needle is a disposable device that consists of an optical fibre sensor embedded within the shaft of a standard nerve block needle up to the needle tip. The needle has a flexible optical fibre cable coming out from the hub in order to connect it to the control unit.
Luer Lock, Female Luer Lock Sideport (Qosina, Ronkonkoma, NY, USA). The female Luer Lock was connected to the syringe, the male Luer Lock was connected to the injection line and an optical fibre pressure sensor was introduced through the valve. The optical fibre pressure sensors are absolute pressure sensors that are factory calibrated. They have a resolution of 0.01 kPa (0.1 mmHg) and an accuracy of AE 0.93 kPa (7 mmHg). Before each injection, sensors were set to zero at ambient pressure.
A total of four porcine lower limb samples were anatomically prepared. Thirty extraneural injections were performed by the authors, as we judged this to be a sufficient number to test the reliability of the sensing needle. The needle tip was placed extraneurally in proximity to, but not in contact with, the tibial nerve under direct vision by surgically dissecting the tissues and isolating the nerve. Next, we injected boluses of 2 ml saline at a controlled infusion rate of 10 ml.min À1 (0.16 ml.s
À1
) with an electronic infusion pump (Alaris IVAC P6000, Carefusion, San Diego, CA, USA). These parameters were chosen to mimic common clinical practice of fractionated injections of small boluses of 2-3 ml of local anaesthetic. Injection pressures were recorded for an overall period of 60 s. For each injection, the software saved the two pressure curves (tip and line pressure) and generated a spreadsheet with pressure values at a sampling rate of 250 Hz. Injection pressure values corresponding to 0.5 ml, 1 ml, 1.5 ml and 2 ml injected volumes were extracted for comparison (2 ml injected volume corresponded to the end of injection). After each injection, the needle tip was then moved to a different location along the tibial nerve before another injection. This was done to avoid injection in extraneural tissues that had already been filled by a previous injection. We therefore limited injections to each lower limb sample to a maximum of eight.
Statistical comparison between tip and line injection pressures was not suitable as these two are linked by flow dynamics laws.
Results
All injections were successfully completed with no technical failures, giving a total of 60 continuous pressure measurements. The system produced accurate continuous measurements and recordings of injection pressure curves during the 60-s timeframe, at both the needle tip and injection line. No sensor malfunction occurred at the needle tip. A sample of a recorded injection pressure profile is illustrated in Fig. 3 . Mean pressures at the needle tip (mean tip pressure), in the injection line (mean line pressure) and the difference in mean pressures (mean line pressure -mean tip pressure) are shown in Table 1 .
The difference between mean (95%CI) pressures progressively increased from 14.33 (12.58-16.08) kPa at 0.5 ml injected volume to 41.56 (39.66-43.45) kPa at the end of the 2.0 ml injection, demonstrating that the difference between the two measured pressures varies substantially during injection.
To demonstrate the impact of the sensor within the needle shaft on the in-line pressures, we performed two injections (with and without the pressure sensor in the needle shaft) with the needle tip in ambient air (Fig. 4) . At the end of the 2 ml injection the pressure difference was 17.83 kPa.
Discussion
This is the first study describing a system designed for real-time continuous monitoring of injection pressures at the tip of a nerve block needle.
Accurate injection pressure measurement at the tip of needles might have multiple potential applications, within regional anaesthetic practice and beyond. It may complement information derived from target-localisation techniques that provide indirect estimation of the nature of the tissue where the needle tip lies, such as nerve stimulation or imaging modalities.
In regional anaesthesia, a millimetric difference in the location of the needle tip could determine whether an injection of local anaesthetic occurs in close proximity to nerves rather than inside the nerve (below the epineural sheath). Intraneural, intrafascicular injections are associated with potentially devastating complications, including permanent nerve injury with Figure 3 Sample of injection pressure profiles at the needle tip ( tip pressure) and in the injection line ( line pressure) for an extraneural needle tip placement with a 2-ml injection at a controlled infusion rate of 10 ml.min Figure 4 Injection pressure curves at the needle tip ( ) and in the injection line ( ) with the tip pressure sensor in situ and injection pressure curve in the injection line without the sensor in the tip ( ) for a 2-ml injection at a controlled infusion rate of 10 ml.min À1 (0.16 ml.s
À1
) with needle tip in ambient air.
consequent loss of function. There is evidence suggesting that intraneural injection associated with high injection pressures leads to nerve damage [6, 8, 9] , as high injection pressures may indicate that the needle tip is intraneural. This is because the epineural sheath is a low-compliance structure, therefore injecting inside the nerve results in a higher injection pressure than injecting outside the sheath. Currently, the only commercially available device for the measurement of injection pressure during peripheral nerve block procedures is the BSmart [11, 12] .
The injection pressure detected by a sensor placed remotely to the needle tip, along the injection line, is influenced by the injection system and its parameters; namely the speed of injection, the size of the needle and the size of the connection tubes. Any injection pressure monitor in the injection line would therefore need to be calibrated and validated for that specific injection system [13, 14] .
Nevertheless, in practice, clinicians erroneously assume that pressures measured in the injection line are equal to pressures at the needle tip. This is only true if there is no flow through the needle. In this respect, Hadzic et al. [9] proposed a definition of the opening injection pressure as the peak pressure at the beginning of injection (during the first 10-15 s), stating that a certain pressure must be overcome (opening pressure) to initiate injection into relatively non-compliant nerve tissue. However, the reality is that local anaesthetic starts flowing out of the needle and into tissues from the beginning of the injection and peak pressure occurs during the injection. Vermeylen et al. have recently demonstrated this phenomenon during simulated nerve blocks of the lower limb in fresh human cadavers [15] . They redefined the opening injection pressure as the peak pressure in the 60-s interval during which the injection is initiated. As such, opening injection pressure has an unclear definition and is confusing. To this regard, we would suggest to simply refer to peak injection pressures to identify the maximum pressure reached during injection, which is the key parameter that should be minimised to avoid nerve damage [6, 8, 9] .
We specifically conceived and built a prototype of an innovative sensing needle, and our results demonstrate that the device is capable of real-time continuous monitoring of injection pressure at the needle tip. We have demonstrated that pressure measured in the injection line is significantly different from that at the needle tip, and the difference between the two varies substantially during the injection period. The relative difference between line pressure and tip pressure increased from the beginning to the end of the injection, by which time the line pressure was > 250% of the tip pressure (68.67 kPa vs. 27.12 kPa, respectively). Without the sensor in the needle shaft, in-line pressures were reduced by approximately 18 kPa and the difference remained significant. Of particular interest is the fact that the difference between tip and line pressures varied during injection, despite using an electronic infusion pump to inject boluses of 2 ml at a constant speed of 10 ml.min À1 (0.16 ml.s À1 ). This is due to the fact that the flow of the liquid out of the needle into tissues is dictated by their compliance, and the evolution of flow during injection determines the variation in the difference between needle tip and line pressure.
As noted by Patil et al. [13] , flow rates exceeding 15 ml.min À1 (0.25 ml.s
) lead to pressure values upstream (in the injection line) at and above those suggestive of intraneural injection. This results from the flow resistance in the needle and in the connection tube. Pressure measured upstream from the needle tip does not distinguish between flow resistance pressures and needle-tip injection pressures. In clinical practice, this is a problem since it creates difficulty in identifying where the measured pressure comes from. A false positive high pressure reading may be wrongly interpreted to represent an intraneural injection. In this regard, Patil et al. [13] suggest limiting the injection rate to 15 ml.min À1 (0.25 ml.s
) to try to limit the influence of flow resistance as the cause of high pressure measured upstream from the needle tip. One might think that measuring pressures upstream in the injection line might provide an extra pressure gap that would protect against an overpressure at the tip. This is incorrect, however, as pressure measurements in the injection line can also give a false negative reading and lead to unintentional intraneural injection.
The pressure difference between the needle and the connection tube is created by the flow dynamics and can be calculated with the Darcy-Weisbach equation, which is the standard empirical relation for pipeflow resistance [16] :
where Dp is the pressure difference in the needle (Pa), f is the Darcy-Weisbach friction factor, L is the length of the needle (m), q is the density of the fluid (kg.m
À3
), V is the velocity of the flow (m.s
À1
), and D is the internal diameter of the needle (m). The velocity of the flow is given by:
where Q is the volumetric flow rate (m 3 .s À1 ), which in practice corresponds to the injection rate. The DarcyWeisbach friction factor is a complex function of Reynolds number and relative pipe roughness. In fluid mechanics the Reynolds number is used to predict the transition from laminar to turbulent flow and for the flow in a pipe it is defined as follows:
where v is the kinematic viscosity (m 2 .s
) and l is the dynamic viscosity (Ns.m
À2
). The most widely accepted nominal range for laminar flow in pipes is Re < 2000. For the needle and injection rate used in this study the Reynolds number was 455. In general, for the needles typically used in regional anaesthesia procedures, an injection rate over 30 ml.min À1 (0.5 ml.s
À1
) is needed to create turbulent flow [13] . In the case of laminar flow, the Darcy-Weisbach friction factor is defined as [16] :
and by substituting Equations (2, 3 and 4) into Equation (1) we obtain the formula:
Equation (5) is well known under the name of the Hagen-Poiseuille law and it gives the pressure difference (Dp) in a pipe with laminar flow. As it can be seen from Equation (5), the pressure difference is not only dependent on the size (length and diameter) but also on the injection rate (Q). The pressure drop in the connection tube is less than that in the needle, as the diameter of the connection tube is bigger and the pressure drop is inversely proportional to the fourth power of the diameter (D). The fibre pressure sensor embedded in the needle creates an increase in flow resistance and therefore also an increase in the upstream, in-line pressure, as the needle internal calibre is reduced. In practice, the pressure measured in the injection line with the sensor in the tip is increased in a similar manner to using a needle with a smaller diameter. This difference has no influence on the measurement at the needle tip (tip pressure), as the sensor in the tip is not affected by the size of the needle, the size of the connection tube or by the speed of injection.
Furthermore, a pressure threshold determined in the injection line will depend on the injection parameters used (size of the needle, size of the connection tube and speed of injection) and it will be valid only for injections using those specific parameters. If parameters change, such as injection speed, an extraneural injection might be wrongly interpreted as an intraneural injection (false positive) when injecting at a higher speed, as the pressure drop in the needle and connection tube is increased. On the other hand, an intraneural injection could be missed (false negative) when injecting at a lower speed, as the pressure drop in the needle and connection tube is reduced and the pressure at the tip can increase accordingly without creating a high pressure reading within the injection line. The only way to have a reliable and reproducible measurement of tip pressure that is unaffected by injection parameters, is by measurement at the needle tip itself. In addition, tip pressure measurement is also able to precisely detect microscopic differences in tissue compliance and can monitor real and objective pressure injection profiles, such as the slope at the beginning of the injection, that could provide important information about tip position [15] .
Our results show that the sensing needle is capable of real-time continuous measurement and acquisition of injection pressures at the needle tip. This might increase the margin of safety by lowering the incidence of complications due to the injection in inappropriate locations. Moreover, line tip pressure monitoring could potentially be used to demonstrate adherence to good clinical practice recommendations, for instance in case of litigation. Our results also demonstrate that one of the safety measures on which the practice of regional anaesthesia is currently based may be influenced by potentially inaccurate measures and false assumptions. This is because injection pressure values measured in the injection line differ significantly from those measured at the needle tip, and the difference between the two varies substantially during injection. This means that injection pressure values measured in the injection line cannot be assumed to be a reliable indicator for the injection pressure at the needle tip, which is the true injection pressure generated in the tissues where the needle tip is positioned.
The extrapolation of our findings to clinical practice is, however, limited by several factors. First, 30 injections were performed without a formal sample size calculation. As this was a feasibility study and all procedures were successful, we believe that the chosen sample size was sufficient to demonstrate preliminary reliability of the device. Second, our measurements are based only on a single needle type and dimension, and on a single flow rate. However, as explained, as tip pressure measurement is not influenced by those factors, the results are valid. Third, injections were performed on animal cadaveric tissues. Although human and animal tissues are comparable, we cannot formally assume that they have equal injection dynamics.
Future work should assess the performance of the sensing needle in human cadaveric tissue and subsequent clinical trials. Before recommending any changes in guidelines or practice, the difference in needle-tip pressure during local anaesthetic injection between extraneural and intraneural needle placement using percutaneous approaches must also be addressed.
